ImpediMed: Shares soar on NCCN Guidelines update
ImpediMed Shares soar on NCCN Guidelines updateImpedimed (IPD) shares soar on Monday after the US National Comprehensive Cancer Network (NCCN) recommends regular screenings...
ImpediMed: Appoints Richard Valencia as MD and CEO
ImpediMed Appoints Richard Valencia as MD and CEOImpediMed (IPD) appoints Richard Valencia as its Managing Director and CEO, effective December 1
Current interim...
ImpediMed: Releases next generation healthcare software
ImpediMed (ASX:IPD) releases next generation healthcare softwareImpediMed (IPD) has released the next generation software for its SOZO Digital Health Platform
Version 4.0 of...

